DOI QR코드

DOI QR Code

Long-term results of ipsilateral radiotherapy for tonsil cancer

  • Koo, Tae Ryool (Department of Radiation Oncology, Seoul National University College of Medicine) ;
  • Wu, Hong-Gyun (Department of Radiation Oncology, Seoul National University College of Medicine)
  • Received : 2013.01.02
  • Accepted : 2013.04.11
  • Published : 2013.06.30

Abstract

Purpose: We evaluated the effectiveness and safety of ipsilateral radiotherapy for the patient with well lateralized tonsil cancer: not cross midline and <1 cm of tumor invasion into the soft palate or base of tongue. Materials and Methods: From 2003 to 2011, twenty patients with well lateralized tonsil cancer underwent ipsilateral radiotherapy. Nineteen patients had T1-T2 tumors, and one patient had T3 tumor; twelve patients had N0-N2a disease and eight patients had N2b disease. Primary surgery followed by radiotherapy was performed in fourteen patients: four of these patients received chemotherapy. Four patients underwent induction chemotherapy followed by concurrent chemoradiotherapy (CCRT). The remaining two patients received induction chemotherapy followed by radiotherapy and definitive CCRT, respectively. No patient underwent radiotherapy alone. We analyzed the pattern of failure and complications. Results: The median follow-up time was 64 months (range, 11 to 106 months) for surviving patients. One patient had local failure at tumor bed. There was no regional failure in contralateral neck, even in N2b disease. At five-year, local progression-free survival, distant metastasis-free survival, and progression-free survival rates were 95%, 100%, and 95%, respectively. One patient with treatment failure died, and the five-year overall survival rate was 95%. Radiation Therapy Oncology Group grade 2 xerostomia was found in one patient at least 6 months after the completion of radiotherapy. Conclusion: Ipsilateral radiotherapy is a reasonable treatment option for well lateralized tonsil cancer. Low rate of chronic xerostomia can be expected by sparing contralateral major salivary glands.

References

  1. Olzowy B, Tsalemchuk Y, Schotten KJ, Reichel O, Harreus U. Frequency of bilateral cervical metastases in oropharyngeal squamous cell carcinoma: a retrospective analysis of 352 cases after bilateral neck dissection. Head Neck 2011;33:239-43. https://doi.org/10.1002/hed.21436
  2. Lim YC, Lee SY, Lim JY, et al. Management of contralateral N0 neck in tonsillar squamous cell carcinoma. Laryngoscope 2005;115:1672-5. https://doi.org/10.1097/01.mlg.0000184791.68804.0b
  3. Chang AR, Wu HG, Park CI, Kim KH, Sung MW, Heo DS. Retrospective analysis of the treatment results for patients with squamous cell carcinoma of tonsil. Cancer Res Treat 2005;37:92-7. https://doi.org/10.4143/crt.2005.37.2.92
  4. Jensen K, Overgaard M, Grau C. Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. Radiother Oncol 2007;85:90-7. https://doi.org/10.1016/j.radonc.2007.06.005
  5. Kagei K, Shirato H, Nishioka T, et al. Ipsilateral irradiation for carcinomas of tonsillar region and soft palate based on computed tomographic simulation. Radiother Oncol 2000;54:117-21. https://doi.org/10.1016/S0167-8140(99)00179-6
  6. Corvo R, Foppiano F, Bacigalupo A, Berretta L, Benasso M, Vitale V. Contralateral parotid-sparing radiotherapy in patients with unilateral squamous cell carcinoma of the head and neck: technical methodology and preliminary results. Tumori 2004;90:66-72.
  7. Perez CA, Patel MM, Chao KS, et al. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys 1998;42:1077-84. https://doi.org/10.1016/S0360-3016(98)00291-0
  8. Yeung AR, Garg MK, Lawson J, et al. ACR Appropriateness $Criteria^{(R)}$ ipsilateral radiation for squamous cell carcinoma of the tonsil. Head Neck 2012;34:613-6. https://doi.org/10.1002/hed.21993
  9. O'Sullivan B, Warde P, Grice B, et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 2001;51:332-43.
  10. Jackson SM, Hay JH, Flores AD, et al. Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol 1999;51:123-8. https://doi.org/10.1016/S0167-8140(99)00051-1
  11. Koo TR, Wu HG, Hah JH, et al. Definitive radiotherapy versus postoperative radiotherapy for tonsil cancer. Cancer Res Treat 2012;44:227-34. https://doi.org/10.4143/crt.2012.44.4.227
  12. Rusthoven KE, Raben D, Schneider C, Witt R, Sammons S, Raben A. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach. Int J Radiat Oncol Biol Phys 2009;74:1365-70. https://doi.org/10.1016/j.ijrobp.2008.10.023
  13. Vergeer MR, Doornaert PA, Jonkman A, et al. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:682-8. https://doi.org/10.1016/j.ijrobp.2009.08.042
  14. Chronowski GM, Garden AS, Morrison WH, et al. Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys 2012;83:204-9. https://doi.org/10.1016/j.ijrobp.2011.06.1975
  15. Cerezo L, Martin M, Lopez M, Marin A, Gomez A. Ipsilateral irradiation for well lateralized carcinomas of the oral cavity and oropharynx: results on tumor control and xerostomia. Radiat Oncol 2009;4:33. https://doi.org/10.1186/1748-717X-4-33
  16. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000;48:329-37.
  17. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol 2006;24:2618-23. https://doi.org/10.1200/JCO.2005.04.7225
  18. Wu Q, Mohan R, Morris M, Lauve A, Schmidt-Ullrich R. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys 2003;56:573-85. https://doi.org/10.1016/S0360-3016(02)04617-5
  19. Toledano I, Graff P, Serre A, et al. Intensity-modulated radiotherapy in head and neck cancer: results of theprospective study GORTEC 2004-03. Radiother Oncol 2012;103:57-62. https://doi.org/10.1016/j.radonc.2011.12.010
  20. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36. https://doi.org/10.1016/S1470-2045(10)70290-4
  21. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704. https://doi.org/10.1016/S0360-3016(01)01512-7
  22. Saarilahti K, Kouri M, Collan J, et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 2006;78:270-5. https://doi.org/10.1016/j.radonc.2006.02.017
  23. Dodds MW, Johnson DA, Yeh CK. Health benefits of saliva: a review. J Dent 2005;33:223-33. https://doi.org/10.1016/j.jdent.2004.10.009
  24. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-39. https://doi.org/10.1016/j.ijrobp.2004.05.050